RxDoctor Payments DataLook up a doctor →

Brian Barry, MD

Neurology · Washington, DCNPI 1013335165

Payments from drug & device makers

$1,506,153in general payments, 2019–2025

Across 362 payments — averaging $4160.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$1M
  • Biogen$182K
  • TG Therapeutics, Inc.$174K
  • E.r. Squibb & Sons, L.L.C.$37K
  • Genentech USA, Inc.$22K
  • Amgen$17K
  • plus $25K from 7 others
$1,664in research payments, 2019–2025

Across 2 payments — averaging $831.81 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis Pharma AG$2K

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis65$1,048,930
Biogen11$182,148
TG Therapeutics, Inc.84$173,818
E.r. Squibb & Sons, L.L.C.31$36,533
Genentech USA, Inc.37$22,286
Amgen(2 entities)66$17,485
Genentech, Inc.7$10,507
Bristol Myers Squibb31$8,427
EMD Serono, Inc.12$5,529
Sanofi13$393
AbbVie(2 entities)3$53
Amneal Pharmaceuticals LLC1$23
AstraZeneca1$23

How this compares

$1,506,153 in reported general payments places this provider in the 95th percentile of 113 neurology providers in District of Columbia.

See all neurology providers in District of Columbia

Medicare billing

Part B allowed, 2024
$93,607
Medicare patients
380
Services billed
777

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →